9.59
price up icon1.70%   0.16
 
loading
Schlusskurs vom Vortag:
$9.43
Offen:
$9.33
24-Stunden-Volumen:
44,517
Relative Volume:
0.48
Marktkapitalisierung:
$89.78M
Einnahmen:
$24.99M
Nettoeinkommen (Verlust:
$-108.83M
KGV:
-0.6381
EPS:
-15.0286
Netto-Cashflow:
$-91.62M
1W Leistung:
+5.85%
1M Leistung:
+4.13%
6M Leistung:
+26.68%
1J Leistung:
-15.96%
1-Tages-Spanne:
Value
$9.261
$9.76
1-Wochen-Bereich:
Value
$8.62
$9.76
52-Wochen-Spanne:
Value
$6.01
$17.44

Adicet Bio Inc Stock (ACET) Company Profile

Name
Firmenname
Adicet Bio Inc
Name
Telefon
617-482-2333
Name
Adresse
131 DARTMOUTH STREET, BOSTON
Name
Mitarbeiter
102
Name
Twitter
Name
Nächster Verdiensttermin
2026-08-06
Name
Neueste SEC-Einreichungen
Name
ACET's Discussions on Twitter

Compare ACET vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
ACET icon
ACET
Adicet Bio Inc
9.59 87.81M 24.99M -108.83M -91.62M -15.03
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
546.12 136.93B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
827.72 85.11B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
1,033.15 64.95B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
145.55 53.23B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
210.02 45.38B 742.00K -1.37B -1.07B -7.0731

Adicet Bio Inc Stock (ACET) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-09-30 Fortgesetzt Guggenheim Buy
2024-09-11 Herabstufung H.C. Wainwright Buy → Neutral
2023-06-27 Herabstufung Guggenheim Buy → Neutral
2023-06-27 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2023-06-01 Herabstufung JP Morgan Overweight → Neutral
2022-09-21 Eingeleitet JP Morgan Overweight
2022-03-31 Eingeleitet SMBC Nikko Outperform
2022-03-08 Eingeleitet Truist Buy
2022-03-04 Eingeleitet Jefferies Buy
2021-05-18 Eingeleitet BTIG Research Buy
2021-04-23 Eingeleitet H.C. Wainwright Buy
2021-04-14 Eingeleitet Canaccord Genuity Buy
2021-04-08 Eingeleitet Guggenheim Buy
2020-11-04 Eingeleitet B. Riley Securities Buy
2020-10-27 Eingeleitet JMP Securities Mkt Outperform
2020-10-16 Eingeleitet Wedbush Outperform
Alle ansehen

Adicet Bio Inc Aktie (ACET) Neueste Nachrichten

pulisher
Aug 19, 2026

ETFs Investing in Adicet Bio Inc Stocks - TradingView

Aug 19, 2026
pulisher
Aug 18, 2026

Are Medical Stocks Lagging Adicet Bio (ACET) This Year? - Yahoo Finance

Aug 18, 2026
pulisher
Aug 16, 2026

ACET Q2 2026 Earnings: Narrower-Than-Expected Loss of $1.99 Per Share Buoys SharesSegment Revenue Breakdown - vinanet.vn

Aug 16, 2026
pulisher
Aug 14, 2026

RA Capital discloses 9.99% Adicet Bio (ACET) stake with warrant blocker - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Adicet Bio (ACET) - Zacks Investment Research

Aug 14, 2026
pulisher
Aug 14, 2026

Adicet Bio: A Cheap Gamma Delta T-Cell Play (NASDAQ:ACET) - Seeking Alpha

Aug 14, 2026
pulisher
Aug 14, 2026

Wall Street Analysts Think Adicet Bio (ACET) Could Surge 301.57%: Read This Before Placing a Bet - Zacks Investment Research

Aug 14, 2026
pulisher
Aug 14, 2026

Adicet Bio's CAR-T therapy shows promise for au... - Pluang

Aug 14, 2026
pulisher
Aug 12, 2026

Adicet Bio (ACET) Edges Higher to $8.26 as Biotech Stock Consolidates Between Key LevelsETF Flow - Vinanet

Aug 12, 2026
pulisher
Aug 12, 2026

HC Wainwright Has Strong Estimate for Adicet Bio Q3 Earnings - MarketBeat

Aug 12, 2026
pulisher
Aug 11, 2026

Adicet Bio at Canaccord Genuity: lupus data drives next step By Investing.com - Investing.com Canada

Aug 11, 2026
pulisher
Aug 11, 2026

Adicet Bio Eyes Key Lupus Data This Quarter for Off-the-Shelf Cell Therapy - MarketBeat

Aug 11, 2026
pulisher
Aug 11, 2026

All You Need to Know About Adicet Bio (ACET) Rating Upgrade to Buy - newsbreak.com

Aug 11, 2026
pulisher
Aug 10, 2026

H.C. Wainwright Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $27 - Moomoo

Aug 10, 2026
pulisher
Aug 07, 2026

JonesTrading Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $20 - Moomoo

Aug 07, 2026
pulisher
Aug 07, 2026

Price to sales forward of Adicet Bio, Inc. – NASDAQ:ACET - TradingView

Aug 07, 2026
pulisher
Aug 07, 2026

Adicet Bio Inc (ACET) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com

Aug 07, 2026
pulisher
Aug 07, 2026

Press Release Service: Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates - CRISPR Medicine News

Aug 07, 2026
pulisher
Aug 06, 2026

Guggenheim cuts Adicet Bio stock price target to $90 on cash position - Investing.com UK

Aug 06, 2026
pulisher
Aug 06, 2026

CCORF Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $18 - Moomoo

Aug 06, 2026
pulisher
Aug 06, 2026

Adicet Bio, Inc. Stock 12‑Month Price Target Cut to $34.4, Implies 276% Upside - TradingView

Aug 06, 2026
pulisher
Aug 05, 2026

ADICET BIO Q2 NET INCOME USD -21.358 MILLION - Moomoo

Aug 05, 2026
pulisher
Aug 05, 2026

ADICET Bio, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 05, 2026
pulisher
Aug 05, 2026

Adicet Bio (NASDAQ:ACET) Posts Earnings Results, Misses Estimates By $0.30 EPS - MarketBeat

Aug 05, 2026
pulisher
Aug 05, 2026

Adicet Bio Q2 net loss narrows - TradingView

Aug 05, 2026
pulisher
Aug 05, 2026

Adicet Bio reports Q2 2026 net loss $21.4M; cash runway into H2 2027, clinical updates planned - TradingView

Aug 05, 2026
pulisher
Aug 05, 2026

Adicet Bio, Inc. 2Q 2026: Revenue $0 Net loss $(21.4)M, EPS $(1.99) — 10-Q Summary - TradingView

Aug 05, 2026
pulisher
Aug 05, 2026

ACET: Q2 2026 net loss narrowed 32% year-over-year; cash runway extends into H2 2027 - TradingView

Aug 05, 2026
pulisher
Aug 05, 2026

BRIEF-Adicet Bio Q2 Basic EPS USD -1.99 - TradingView

Aug 05, 2026
pulisher
Aug 05, 2026

ACET Q2'26 Earnings: EPS estimate is (1.69) USD - tradingview.com

Aug 05, 2026
pulisher
Aug 03, 2026

More Than Two Decades at Johnson & Johnson: Lipocine's New Director - stocktitan.net

Aug 03, 2026
pulisher
Aug 03, 2026

Adicet Bio Inc expected to post a loss of $2.03 a shareEarnings Preview - TradingView

Aug 03, 2026
pulisher
Aug 02, 2026

ACET Q1 2026 Earnings: Narrower Loss Beats Estimates by 40.74% as Clinical Pipeline AdvancesConsensus Miss Rate - vinanet.vn

Aug 02, 2026
pulisher
Aug 01, 2026

Adicet Bio Inc Actuals & Estimates (NASDAQ:ACET) - TradingView

Aug 01, 2026
pulisher
Jul 30, 2026

Adicet Bio (NASDAQ:ACET) Share Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat

Jul 30, 2026
pulisher
Jul 27, 2026

Adicet Bio, Inc. Revenue Breakdown – NASDAQ:ACET - TradingView

Jul 27, 2026
pulisher
Jul 27, 2026

Adicet Bio Inc (ACET) Balance Sheet - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Adicet Bio Inc (ACET) Cash Flow - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Adicet Bio: A 400% Upside Bet on Gamma Delta T-Cell Data - Kavout | AI

Jul 27, 2026
pulisher
Jul 27, 2026

Adicet Bio Inc Revenue Breakdown – TRADEGATE:1IJ - TradingView

Jul 27, 2026
pulisher
Jul 27, 2026

Adicet Bio Inc (ACET) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

Adicet Bio Inc (ACET) Income Statement - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Adicet Bio Inc (ACET) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Adicet Bio Inc (ACET) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Adicet Bio Inc (ACET) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

ACET|Adicet Bio Inc|Price:8.140|Chg%:+0.350 - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

Adicet Bio Market Sentiment - Benzinga España

Jul 25, 2026
pulisher
Jul 25, 2026

Adicet Bio (ACET) Faces Pressure as Shares Slide Over 7% – Key Levels in FocusCatalyst Driven Stocks - vinanet.vn

Jul 25, 2026
pulisher
Jul 24, 2026

ACET Q1 2026 Earnings: EPS Surprise of 40.7% Mitigates Quarterly Loss, Shares Trade LowerOne-Time Loss Impact - vinanet.vn

Jul 24, 2026
pulisher
Jul 23, 2026

ACET Q1 2026 Earnings: Narrower-Than-Expected Loss Drives 5.54% Share Price GainPost-Earnings Drift - vinanet.vn

Jul 23, 2026
pulisher
Jul 22, 2026

Adicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference - BioSpace

Jul 22, 2026

Finanzdaten der Adicet Bio Inc-Aktie (ACET)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Adicet Bio Inc-Aktie (ACET) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Feb 19 '26
Buy
7.21
74,268
535,472
1,107,873
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Feb 18 '26
Buy
7.04
74,577
525,022
1,033,605
ORBIMED ADVISORS LLC
10% Owner
Apr 08 '26
Sale
6.42
72,939
468,082
0
ORBIMED ADVISORS LLC
10% Owner
Apr 07 '26
Sale
6.52
31,719
206,765
32,523
$103.76
price up icon 0.86%
$126.29
price down icon 0.31%
$63.96
price up icon 0.13%
$266.11
price up icon 0.61%
ONC ONC
$358.26
price down icon 1.22%
$210.02
price down icon 0.40%
Kapitalisierung:     |  Volumen (24h):